WHO-GMP Certified Commercial Supply

VEERIX-LULICONAZOLE Cream Contract Manufacturing & CDMO

Veerix Biotech is a WHO-GMP certified third-party pharmaceutical manufacturer and CDMO partner producing VEERIX-LULICONAZOLE Cream (LULICONAZOLE IP CREAM) within the Derma therapeutic class, with complete Certificate of Analysis (CoA), stability studies, and regulatory dossier compliance for domestic Indian and global export markets.

Post Your Requirement for VEERIX-LULICONAZOLE Cream →

Technical Specifications & Formulation Details

Product NameVEERIX-LULICONAZOLE Cream
Active CompositionLULICONAZOLE IP CREAM
Therapeutic SegmentDerma
Dosage FormOintments
Primary Packaging15g / 30g
Quality StandardIP / BP / USP Pharmacopeial Standard, WHO-GMP Certified
Manufacturing FacilityTahliwal Industrial Area, Tehsil Haroli, Una, Himachal Pradesh & Coimbatore, Tamil Nadu
Regulatory DocumentationBatch Release CoA, Method of Analysis (MOA), Accelerated & Real-time Stability Data, CTD Module 3

Commercial Supply Capabilities for VEERIX-LULICONAZOLE Cream

Veerix Biotech provides end-to-end commercial supply and technical scoping for VEERIX-LULICONAZOLE Cream in the Derma class. From pre-formulation screening and pilot batch validation to automated blister packaging, serialisation, and multi-market regulatory clearance, our direct facilities and audited partner network ensure seamless execution.

  • Custom private label packaging with brand foil printing and anti-counterfeit features
  • Batch volume scalability: from pilot validation batches to large-scale commercial export runs
  • Dedicated QA/QC release testing including HPLC assay, dissolution testing, and microbial limits
  • Strict confidentiality with mutual non-disclosure agreement (NDA) upfront
← View all Derma Formulations View General Dermatological Molecules Molecule Profile Request Batch Pricing →